{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:08:48Z","timestamp":1771373328576,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.bbrc.2011.06.151","type":"journal-article","created":{"date-parts":[[2011,7,4]],"date-time":"2011-07-04T16:20:17Z","timestamp":1309796417000},"page":"370-374","source":"Crossref","is-referenced-by-count":15,"title":["Neuroprotective cytokines repress PUMA induction in the 1-methyl-4-phenylpyridinium (MPP+) model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"411","author":[{"given":"Yeon-Hee","family":"Kook","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minhan","family":"Ka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moonkyoung","family":"Um","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2011.06.151_b0005","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/01.wnl.0000312279.49272.9f","article-title":"Invited article: nervous system pathology in sporadic Parkinson disease","volume":"70","author":"Braak","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2011.06.151_b0010","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2011.06.151_b0015","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm.2165","article-title":"Missing pieces in the Parkinson\u2019s disease puzzle","volume":"16","author":"Obeso","year":"2010","journal-title":"Nat. Med."},{"issue":"Suppl. 5","key":"10.1016\/j.bbrc.2011.06.151_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00415-008-5011-4","article-title":"Update on the pathogenesis of Parkinson\u2019s disease","volume":"255","author":"Schulz","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbrc.2011.06.151_b0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cytogfr.2008.01.004","article-title":"Raves and risks for erythropoietin","volume":"19","author":"Maiese","year":"2008","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bbrc.2011.06.151_b0030","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.2174\/092986708784567671","article-title":"Old friends in new constellations \u2013 the hematopoetic growth factors G-CSF, GM-CSF, and EPO for the treatment of neurological diseases","volume":"15","author":"Maurer","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbrc.2011.06.151_b0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.critrevonc.2007.03.001","article-title":"Role of erythropoietin in the brain","volume":"64","author":"Noguchi","year":"2007","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbrc.2011.06.151_b0040","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1152\/physiol.00016.2008","article-title":"Brain protection by erythropoietin: a manifold task","volume":"23","author":"Rabie","year":"2008","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.bbrc.2011.06.151_b0045","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.4161\/cc.4.12.2213","article-title":"A role for G-CSF (granulocyte-colony stimulating factor) in the central nervous system","volume":"4","author":"Schneider","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbrc.2011.06.151_b0050","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/01.STR.0000208205.26253.96","article-title":"A novel neuroprotectant granulocyte-colony stimulating factor","volume":"37","author":"Solaroglu","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.bbrc.2011.06.151_b0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/156652407780059186","article-title":"Hematopoietic cytokines \u2013 on the verge of conquering neurology","volume":"7","author":"Tonges","year":"2007","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.bbrc.2011.06.151_b0060","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1471-4159.2006.04125.x","article-title":"Recombinant human granulocyte colony-stimulating factor protects against MPTP-induced dopaminergic cell death in mice by altering Bcl-2\/Bax expression levels","volume":"99","author":"Cao","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2011.06.151_b0065","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.yexcr.2010.01.001","article-title":"Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures","volume":"316","author":"Ganser","year":"2010","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbrc.2011.06.151_b0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0304-3940(02)00041-1","article-title":"Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro","volume":"321","author":"Genc","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2011.06.151_b0075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0304-3940(00)01716-X","article-title":"Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57\/BL mice via increasing nitric oxide production","volume":"298","author":"Genc","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2011.06.151_b0080","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.neurobiolaging.2006.05.037","article-title":"G-CSF protects dopaminergic neurons from 6-OHDA-induced toxicity via the ERK pathway","volume":"28","author":"Huang","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbrc.2011.06.151_b0085","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.brainres.2008.11.094","article-title":"Continuous intraventricular infusion of erythropoietin exerts neuroprotective\/rescue effects upon Parkinson\u2019s disease model of rats with enhanced neurogenesis","volume":"1254","author":"Kadota","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.bbrc.2011.06.151_b0090","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s12035-010-8118-4","article-title":"Post-MPTP treatment with granulocyte colony-stimulating factor improves nigrostriatal function in the mouse model of Parkinson\u2019s disease","volume":"41","author":"McCollum","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbrc.2011.06.151_b0095","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1471-4159.2006.03727.x","article-title":"Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson\u2019s disease","volume":"97","author":"Meuer","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2011.06.151_b0100","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2006.07.004","article-title":"HSV-mediated delivery of erythropoietin restores dopaminergic function in MPTP-treated mice","volume":"14","author":"Puskovic","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2011.06.151_b0105","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1471-4159.2005.03587.x","article-title":"Erythropoietin protects against 6-hydroxydopamine-induced dopaminergic cell death","volume":"96","author":"Signore","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2011.06.151_b0110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.neulet.2010.10.012","article-title":"Granulocyte-colony stimulating factor (G-CSF) enhances recovery in mouse model of Parkinson\u2019s disease","volume":"487","author":"Song","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2011.06.151_b0115","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/gt.2009.113","article-title":"AAV9-mediated erythropoietin gene delivery into the brain protects nigral dopaminergic neurons in a rat model of Parkinson\u2019s disease","volume":"17","author":"Xue","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.bbrc.2011.06.151_b0120","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.neuroscience.2007.02.004","article-title":"Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson\u2019s disease","volume":"146","author":"Xue","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbrc.2011.06.151_b0125","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1096\/fj.05-3941fje","article-title":"Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1\/-2 and Akt pathways","volume":"19","author":"Kilic","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2011.06.151_b0130","doi-asserted-by":"crossref","first-page":"10291","DOI":"10.1523\/JNEUROSCI.22-23-10291.2002","article-title":"Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model","volume":"22","author":"Ruscher","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2011.06.151_b0135","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/jnr.10166","article-title":"Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up-regulating Bcl-xL expression","volume":"67","author":"Wen","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbrc.2011.06.151_b0140","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s10495-007-0065-9","article-title":"Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt\/GSK-3beta\/caspase-3 mediated signaling pathway","volume":"12","author":"Wu","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbrc.2011.06.151_b0145","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s11064-005-6877-5","article-title":"Puma and p53 play required roles in death evoked in a cellular model of Parkinson disease","volume":"30","author":"Biswas","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbrc.2011.06.151_b0150","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/j.1471-4159.2007.05115.x","article-title":"6-Hydroxydopamine activates the mitochondrial apoptosis pathway through p38 MAPK-mediated, p53-independent activation of Bax and PUMA","volume":"104","author":"Gomez-Lazaro","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2011.06.151_b0155","doi-asserted-by":"crossref","first-page":"12500","DOI":"10.1523\/JNEUROSCI.4511-08.2008","article-title":"Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice","volume":"28","author":"Karunakaran","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2011.06.151_b0160","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10495-006-6316-3","article-title":"Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson\u2019s disease","volume":"11","author":"Nair","year":"2006","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbrc.2011.06.151_b0165","doi-asserted-by":"crossref","first-page":"11318","DOI":"10.1073\/pnas.201208798","article-title":"Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals","volume":"98","author":"Han","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2011.06.151_b0170","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1097-2765(01)00214-3","article-title":"PUMA, a novel proapoptotic gene, is induced by p53","volume":"7","author":"Nakano","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2011.06.151_b0175","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1097-2765(01)00213-1","article-title":"PUMA induces the rapid apoptosis of colorectal cancer cells","volume":"7","author":"Yu","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2011.06.151_b0180","doi-asserted-by":"crossref","first-page":"12989","DOI":"10.1523\/JNEUROSCI.3400-07.2007","article-title":"Puma is a dominant regulator of oxidative stress induced Bax activation and neuronal apoptosis","volume":"27","author":"Steckley","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2011.06.151_b0185","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1471-4159.2005.03676.x","article-title":"The BH3-only protein puma is both necessary and sufficient for neuronal apoptosis induced by DNA damage in sympathetic neurons","volume":"96","author":"Wyttenbach","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2011.06.151_b0190","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/sj.onc.1210220","article-title":"The Bcl-2 apoptotic switch in cancer development and therapy","volume":"26","author":"Adams","year":"2007","journal-title":"Oncogene"},{"issue":"Suppl. 1","key":"10.1016\/j.bbrc.2011.06.151_b0195","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/onc.2009.45","article-title":"PUMA, a potent killer with or without p53","volume":"27","author":"Yu","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2011.06.151_b0200","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.bbrc.2005.03.188","article-title":"P53-A pro-apoptotic signal transducer involved in AIDS","volume":"331","author":"Castedo","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2011.06.151_b0205","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1535-6108(03)00244-7","article-title":"Puma is an essential mediator of p53-dependent and -independent apoptotic pathways","volume":"4","author":"Jeffers","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2011.06.151_b0210","doi-asserted-by":"crossref","first-page":"20606","DOI":"10.1073\/pnas.0707906105","article-title":"Deletion of the BH3-only protein puma protects motoneurons from ER stress-induced apoptosis and delays motoneuron loss in ALS mice","volume":"104","author":"Kieran","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2011.06.151_b0215","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neulet.2009.01.019","article-title":"Effects of transient focal cerebral ischemia in mice deficient in puma","volume":"451","author":"Kuroki","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2011.06.151_b0220","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/STROKEAHA.108.524447","article-title":"Potential role of PUMA in delayed death of hippocampal CA1 neurons after transient global cerebral ischemia","volume":"40","author":"Niizuma","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.bbrc.2011.06.151_b0225","doi-asserted-by":"crossref","first-page":"H52","DOI":"10.1152\/ajpheart.01046.2005","article-title":"Targeted deletion of puma attenuates cardiomyocyte death and improves cardiac function during ischemia\u2013reperfusion","volume":"291","author":"Toth","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbrc.2011.06.151_b0230","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.1090072","article-title":"p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa","volume":"302","author":"Villunger","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2011.06.151_b0235","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.cellsig.2006.08.014","article-title":"A \u201cclassical\u201d homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells","volume":"19","author":"Um","year":"2007","journal-title":"Cell Signal."},{"key":"10.1016\/j.bbrc.2011.06.151_b0240","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1074\/jbc.M510943200","article-title":"Antiapoptotic effects of erythropoietin in differentiated neuroblastoma SH-SY5Y cells require activation of both the STAT5 and AKT signaling pathways","volume":"281","author":"Um","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.06.151_b0245","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","article-title":"Toxin-induced models of Parkinson\u2019s disease","volume":"2","author":"Bove","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.bbrc.2011.06.151_b0250","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0304-3940(85)90342-8","article-title":"Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and several of its analogues on the dopaminergic nigrostriatal pathway in mice","volume":"58","author":"Heikkila","year":"1985","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2011.06.151_b0255","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0024-3205(85)90059-1","article-title":"MPTP neurotoxicity: an overview and characterization of phases of toxicity","volume":"36","author":"Langston","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2011.06.151_b0260","first-page":"135","article-title":"The parkinsonian toxin MPTP: action and mechanism","volume":"16","author":"Przedborski","year":"2000","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.bbrc.2011.06.151_b0265","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1023\/B:JOBB.0000041771.66775.d5","article-title":"MPTP as a mitochondrial neurotoxic model of Parkinson\u2019s disease","volume":"36","author":"Przedborski","year":"2004","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.bbrc.2011.06.151_b0270","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1006\/cbir.1995.1118","article-title":"Involvement of tubulin in MPP+ neurotoxicity on NGF-differentiated PC12 cells","volume":"19","author":"Cappelletti","year":"1995","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bbrc.2011.06.151_b0275","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1471-4159.1987.tb02909.x","article-title":"A dopaminergic cell line variant resistant to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"49","author":"Denton","year":"1987","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2011.06.151_b0280","article-title":"Anti-apoptotic effect of Mao-B inhibitor PF9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] is mediated by p53 pathway inhibition in MPP(+)-treated SH-SY5Y human dopaminergic cells","volume":"23","author":"Sanz","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2011.06.151_b0285","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.10350","article-title":"p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism","volume":"52","author":"Duan","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2011.06.151_b0290","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/neur.1996.0031","article-title":"Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity","volume":"5","author":"Trimmer","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.bbrc.2011.06.151_b0295","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.neuro.2004.12.008","article-title":"Selective alterations of transcription factors in MPP+-induced neurotoxicity in PC12 cells","volume":"26","author":"Xu","year":"2005","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbrc.2011.06.151_b0300","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4161\/cc.2.2.303","article-title":"Akt inhibits DNA damage by suppressing p73, p53, forkhead or all three?","volume":"2","author":"Basu","year":"2003","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbrc.2011.06.151_b0305","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.semcdb.2004.01.002","article-title":"PI 3-kinase Akt and cell survival","volume":"15","author":"Downward","year":"2004","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2011.06.151_b0310","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/sj.onc.1202439","article-title":"Thrombopoietin-induced conformational change in p53 lies downstream of the p44\/p42 mitogen activated protein kinase cascade in the human growth factor-dependent cell line M07e","volume":"18","author":"Ritchie","year":"1999","journal-title":"Oncogene"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X11011508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X11011508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T18:25:39Z","timestamp":1560363939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X11011508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0006291X11011508"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2011.06.151","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}